Diploma upgrades FY26 guidance after strong H1 trading

Diploma Plc

Diploma PLC (LON:DPLM), the value-add solutions group, has issued an update reflecting strong trading, and upgrades FY26 guidance.

·      Trading remains very strong. Great performance continues through H1. Confident in H2 momentum.

·      Upgraded FY26 guidance

o  Organic revenue growth increased to 9% (from 6%), remaining H1 weighted

o  Net acquisition growth unchanged at 3%. This will increase if further acquisitions are made

o  Operating margin increased to c.25% (from c.22.5%)

o  Representing a c.13% upgrade to consensus operating profit1

o  We expect another year of sustainable quality compounding, with earnings growth over 20%
at strong returns on capital

·      Strong growth across diversified portfolio:

Controls:

o  Peerless – Aerospace demand and supply characteristics are favourable and sustainable.
We have a proven track record of executing on growth opportunities. We expect another outstanding organic growth performance in the first half, with the second half returning to more typical growth rates against very strong comparators. 

o  Other Controls businesses also growing strongly – IS Group and Clarendon continue to execute well in structurally growing markets like energy, defence and aerospace. 
Windy City Wire is performing very well. Strong growth supported by excellent execution in markets including datacentres and digital antenna systems. We expect H2 growth to be good against strong comparators.

Seals:

o  North American Seals continues to show good progress, with strong core business growth in infrastructure and exciting developments in nuclear power generation. International Seals remains challenging – particularly in the UK – and will somewhat hold back overall Seals H1 growth rates, consistent with FY25 growth rates.

Life Sciences:

o  Performing consistently in a tough healthcare market, with share gains across medtech and IVD.

Organic growth excluding Peerless is strong and well ahead of our financial model.

·      Margins continue to expand driven by accretive contribution from Peerless and steady accretion across the rest of the Group.

·      Acquisition momentum continues – As reported in January, we completed 8 acquisitions in the preceding two quarters for c.£130m with expected annualised operating profit contribution of c.£20m. With a healthy short-term pipeline, we feel optimistic about this momentum continuing in the months ahead. Potential acquisitions are not reflected in our guidance. 

Johnny Thomson, Chief Executive Officer, and Wilson Ng, Chief Financial Officer, will host a conference call for analysts and investors this morning at 8:00am (UK time).

Conference call dial in details:

• Dial in: +44 (0) 33 0551 0200 / 0808 109 0700

• Password: Teneo

Our next scheduled update is our half year results on 19 May 2026.

Notes:
1. Analyst consensus adjusted operating profit for FY26 is £377m, as at 17 March 2026.

Share on:

Latest Company News

Cora Gold confirms Eagle Eye shareholding transfer and gold stream restructuring to A2MP

Cora Gold says its largest shareholder plans to transfer its stake and gold stream rights to subsidiary A2MP Investments FZCO.

Elemental Royalty holds more than 200 royalties across global mining sector

Elemental Royalty holds more than 200 royalties, including 18 producing assets and 28 advanced development projects across four continents.

Hercules expects FY26 results to beat expectations as revenue passes £130m

Hercules expects full-year revenue, underlying EBITDA and statutory PBT to come in ahead of market expectations.

Geiger Counter highlights strong uranium market fundamentals and growing nuclear demand

Geiger Counter Limited’s September 2026 factsheet highlights the constructive long-term outlook for uranium, supported by rising nuclear power demand, energy security priorities and constrained supply.

City Natural Resources Chairman Christopher Casey outlines Tufton’s investment strategy

Chairman Christopher Casey explains how Tufton Investment Management’s shipping expertise, investment platform and resources will support the trust in identifying natural resources opportunities and creating value for shareholders.

Physitrack CEO Henrik Molin outlines EMR Launch, AI strategy and 2027 growth plans

Physitrack CEO Henrik Molin discusses 14% year-on-year revenue growth, early sign-ups for its new electronic medical record system, remote therapeutic monitoring and plans to expand its AI-powered healthcare technology offering in 2027.

    Search